Medpace Holdings, Inc. (MEDP) stock: key figures, P/E, revenue and dividend
Industrials · United States · ISIN US58506Q1094
Medpace Holdings, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 2.53 bn USD |
| Operating income | 534.94 m USD |
| EBIT | 542.38 m USD |
| Net income | 451.12 m USD |
| Diluted EPS – continuing operations | 15.28 USD |
Full history since 2013, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Medpace Holdings, Inc.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
More stocks
- Wartsila Oyj Abp (WRT1V.HE)
- Kubota Corp (6326.T)
- SDIC Power Holdings Co Ltd (600886.SS)
- Shanghai International Port Group Co Ltd (600018.SS)
- Banca Mediolanum SpA (BMED.MI)
- Telefônica Brasil S.A. (VIVT3.SA)
- Essity AB (publ) (ESSITY B.ST)
- Galp Energa (GLPEY)
- Straumann Holding AG (STMN.SW)
- Kingspan Group PLC (KRX.IR)
- Nippon Yusen KK (9101.T)
- Fubon Financial Holding Co Ltd Pref B (2881B.TW)
Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.